Comparative and Combinatorial Effects of Resveratrol and Sacubitril/Valsartan alongside Valsartan on Cardiac Remodeling and Dysfunction in MI-Induced Rats.

Molecules · 2021 · PMC8401506 · PMID 34443591

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a clear trendno p-value reported

However, no statistically significant incremental benefit was observed with the sacubitril/valsartan + resveratrol combination treatment, despite a clear trend towards a further reduction in cardiac remodeling and enhanced systolic function (≥4% increase in LVEF), than with individual treatments.

also in 19,460 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.